Evidence map›Paper›PMID 37612102›Full record

ArticleBMJ open2023

A cross-sectional study to evaluate hypovitaminosis C prevalence and risk factors in an acute geriatric unit in Lyon, France: the HYPO-VIT-C protocol.

Alfred Quillon, Laure Guittard, Karine Goldet, Madeleine Etienne, Emilie Blond, Mikail Nourredine, Géraldine Martin-Gaujard, Sébastien Doh

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05668663 (Hypovitaminosis C Prevalence and Risk Factors in an Acute Geriatric Unit), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05668663 nacompletednot on this map

Hypovitaminosis C Prevalence and Risk Factors in an Acute Geriatric Unit

TypeinterventionalSponsorHospices Civils de LyonRan2023 to 2024Enrolled434ConditionsDeficiency, Vitamin CArmsPlasmatic Vitamin C concentrations (known as ascorbemia) on a single blood sample
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alfred QuillonService de médecine gériatrique, Hospices Civils de Lyon, Lyon, France alfred.quillon@chu-lyon.fr.ORCID 0009-0001-6392-9605
Laure GuittardPôle Santé Publique, Service Recherche et Epidémiologie cliniques, Hospices Civils de Lyon, Lyon, France.
Karine GoldetClinical Research Centre, Ageing, Brain, Fragility - Hôpital des Charpennes, Hospices Civils de Lyon, Villeurbanne, France.
Madeleine EtienneClinical Research Centre, Ageing, Brain, Fragility - Hôpital des Charpennes, Hospices Civils de Lyon, Villeurbanne, France.
Emilie BlondDepartment of Biochemistry, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France.
Mikail NourredineDepartment of biostatistics, Hospices Civils de Lyon, Lyon, France.
Géraldine Martin-GaujardService de médecine gériatrique, Hospices Civils de Lyon, Lyon, France.
Sébastien DohService de médecine gériatrique, Hospices Civils de Lyon, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVitamin C is an essential micronutrient playing crucial roles in human biology. Hypovitaminosis C is defined by a plasmatic ascorbemia below 23 µmol/L and is associated with numerous outcomes such as cardiovascular diseases, cancers or neurocognitive disorders. Numerous risk factors are common among older adults making them particularly susceptible to hypovitaminosis C. These risk factors include reduced vitamin intakes, higher vitamin metabolism related to polypathology, and iatrogeny because of polypharmacy. However, the precise prevalence of hypovitaminosis C and its risk factors are poorly documented within the geriatric population.A better knowledge of hypovitaminosis C prevalence and risk factor may lead to improving the vitamin C status among older people and prevent its consequences. METHOD AND ANALYSIS: To answer these questions, we designed a monocentric cross-sectional study in a population of older hospitalised patients in Lyon, France. A sample size of 385 patients was needed to estimate hypovitaminosis C prevalence. The study was proposed to all eligible patient aged more than 75 years old entering the participating acute geriatric unit. The plasmatic vitamin C status was systematically assessed for participating patients, and variables part of the medical and geriatric evaluation were collected. For patients with severe vitamin C depletion, an oral supplementation and a follow-up phone call were organised to ensure treatment completion and tolerance. ETHICS AND DISSEMINATION: The protocol has been approved by an independent national ethics committee and meets the methodological requirements. Final outcomes will be published in a peer-reviewed journal and disseminated through conferences. TRIAL REGISTRATION NUMBER: NCT05668663.

Indexed as

Ascorbic AcidAvitaminosisAgedCross-Sectional StudiesFranceHumansPrevalenceRisk FactorsVitaminsAscorbic AcidVitaminsagingepidemiologypublic healthrisk factors

Identifiers

PMID37612102
PMCPMC10450057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.